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EDITORIALThe Increasing Role of the Vascular Surgeon in Critical Limb IschaemiaCritical limb ischaemia (CLI) affects an increasing number of
patients with a risk of cardiac morbidity and mortality,
a poor quality of life with a high risk of limb loss.1,2 Given
the evolving demographics and the increasing prevalence of
CLI in the ageing Western countries, there has been an
enhanced focus on developing a safe and effective treat-
ment for CLI.
A patient affected by CLI needs a multidisciplinary
approach, which could consist of all available tools from
medical, surgical or endovascular therapy. Previous reports
mainly for the 1990s suggested that endovascular therapies
could reduce morbidity, mortality, length of stay and limb
loss.3e5 Moreover, in the recent years, the hybrid approach
(HA) combining in the same setting a surgical reconstruction
and a transluminal angioplasty has been an interesting
alternative for patients with CLI.
Such a complementary use of endovascular procedures
and surgical revascularisation has been validated in
numerous reports.6e10 The HA can offer the best of both
surgical and endovascular approaches within a unique and
less-invasive procedure done under local anaesthesia,
a short stay with a rapid recovery. In our experience, HA has
been currently used to increase either the inﬂow or the
runoff in order to extend the pathway of the revascular-
isation in different anatomical territories.
As a proof, Brewster et al.6 reported a favourable 76% 5-
year graft patency rate in 79 patients receiving an iliac
artery angioplasty followed by a bypass to the lower limb.
Similarly, Faries et al.9 reported a 3-year patency rate of
71% in 126 patients receiving an iliac artery angioplasty
followed by an infrainguinal bypass. Madera et al.,11 among
239 endovascular procedures, reported 108 hybrid proce-
dures performed by vascular surgeons in the operating
room. In this series, the technical success rate of the
angioplasty procedure was 90%, the highest rate for prox-
imal lesions. Similar results were obtained by Dougherty
et al.12 with a few late graft occlusions in relation with the
restenosis of the angioplasty site.
All these series demonstrated that HA offers the advan-
tage of a combined procedure with an acceptable limb
salvage similar to that reported in the Trans-Atlantic Inter-
Society Consensus on the Management of Peripheral Arte-
rial Disease (TASC II) document13 with the need for a careful
follow-up and an aggressive re-intervention policy. Many
reports have documented the safety of these endovascular
procedures done by vascular surgeons in the operating
room.14e24 An appropriate follow-up protocol with
a prompt re-intervention whenever feasible is of paramount1078-5884/$ e see front matter  2012 European Society for Vascular
Surgery. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2012.11.002importance, and according to our opinion, the vascular
surgeon is the best specialist to take care of these patients,
even if this is still debated.25,26
In conclusion, I believe that the treatment of CLI must be
managed by vascular surgeons in high-volume vascular
centres. The vascular surgeon knows better than anybody
else does the pathology, the anatomy, the haemodynamics
and the lesion characteristics. This knowledge, combined
with that of both surgical and endovascular procedures,
makes the vascular surgeon, the best physician to take care
of the patients with CLI.
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